Replies to post #4131 on Avid Bioservices Inc (CDMO)

[mskatiescarletohara]

Mark....I'm quite pleased with the prospects moving forward.

Safety study for HCV is done at this time, we await results and an update on what plans are for proceeding to Phase Ib. PPS at a 1.50.

Not sure why some folks are in a tizz, but I await the day when 25 + million shares get traded in one day.

Safety data from Phase I HCV is on the horizon. True value is realized for Tarvacin when the FDA God's say YEAH...move ahead.

The PR in mid-January insinuated such....

katie....